Visual Processing Speed and Objective Analysis of Ocular Movements in Multiple Sclerosis

NCT ID: NCT05706220

Last Updated: 2025-05-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-06-13

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project aims to analyze ocular motility problems, visual processing speed and microperimetry, and their relationship with consolidated retinal structural biomarkers (optical coherence tomography, OCT) in patients with Multiple Sclerosis w/w reading complaints comparing with healthy subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anamnesis, ophthalmological medical history including difficulties in reading with appropriate glasses.

The following protocol will be applied:

* Comprehensive eye examination
* Stereopsis
* Primary gaze position
* Cover test: far and near
* Vergence and version eye movements
* Presence of nystagmus
* Far and near best corrected visual acuity, with updated refraction

-.Pupillary light reflex
* Biomicroscopy of the anterior pole
* Intraocular pressure
* Recording of eye movements during two standardized tests: International Reading Speed Texts test (IReST®) and Developmental Eye Movement Test (DEM™) with Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software.
* Visual processing speed
* Microperimetry
* Optical coherence tomography
* Eye fundus
* Patients with a history of clinical optic neuritis will additionally undergo contrast sensitivity tests, the Farnsworth® test (Farnsworth test 28 Hue x 100) and normal monocular perimetry using the standard Swedish Interactive Thresholding Algorithm (SITA-central 24-2) perimeter test. Humphrey® (Humphrey visual field analyser) and other tests at the discretion of the investigator.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis Clinically Isolated Syndrome Relapsing Remitting Multiple Sclerosis Progressive Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control group

* Ophthalmologic examination (best-corrected visual acuity, cover and uncover tests, slit-lamp biomicroscopy, funduscopy)
* Eye movement recording with the Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software
* Visual processing speed
* Microperimetry
* Optical coherence tomography

Eye tracking

Intervention Type DIAGNOSTIC_TEST

Eye tracker will be used to evaluate eye movements

Microperimetry

Intervention Type DIAGNOSTIC_TEST

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Visual processing speed test

Intervention Type DIAGNOSTIC_TEST

Visual processing speed test will be used for assessing subject visual stimulus search and reach times.

Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Clinically Isolated Syndrome Patients

* Ophthalmologic examination
* Eye movement recording with the Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software
* Visual processing speed
* Microperimetry
* Optical coherence tomography
* Patients with a history of optic neuritis will undergo additional tests at the discretion of the researcher (e.g. visual field, FarnsworthTest)

Eye tracking

Intervention Type DIAGNOSTIC_TEST

Eye tracker will be used to evaluate eye movements

Microperimetry

Intervention Type DIAGNOSTIC_TEST

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Visual processing speed test

Intervention Type DIAGNOSTIC_TEST

Visual processing speed test will be used for assessing subject visual stimulus search and reach times.

Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Relapsing-remitting Multiple Sclerosis Patients

* Ophthalmologic examination (best-corrected visual acuity, cover and uncover tests, slit-lamp biomicroscopy, funduscopy)
* Eye movement recording with the Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software
* Visual processing speed
* Microperimetry
* Optical coherence tomography
* Patients with a history of optic neuritis will undergo additional tests at the discretion of the researcher (e.g. visual field, FarnsworthTest)

Eye tracking

Intervention Type DIAGNOSTIC_TEST

Eye tracker will be used to evaluate eye movements

Microperimetry

Intervention Type DIAGNOSTIC_TEST

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Visual processing speed test

Intervention Type DIAGNOSTIC_TEST

Visual processing speed test will be used for assessing subject visual stimulus search and reach times.

Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Primary Progressive Multiple Sclerosis Patients

* Ophthalmologic examination (best-corrected visual acuity, cover and uncover tests, slit-lamp biomicroscopy, funduscopy)
* Eye movement recording with the Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software
* Visual processing speed
* Microperimetry
* Patients with a history of optic neuritis will undergo additional tests at the discretion of the researcher (e.g. visual field, FarnsworthTest)
* Optical coherence tomography

Eye tracking

Intervention Type DIAGNOSTIC_TEST

Eye tracker will be used to evaluate eye movements

Microperimetry

Intervention Type DIAGNOSTIC_TEST

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Optical coherence tomography (OCT)

Intervention Type DIAGNOSTIC_TEST

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Visual processing speed test

Intervention Type DIAGNOSTIC_TEST

Visual processing speed test will be used for assessing subject visual stimulus search and reach times.

Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Eye tracking

Eye tracker will be used to evaluate eye movements

Intervention Type DIAGNOSTIC_TEST

Microperimetry

Perimetric examination with Expert Exam strategy Microperimetry be used for fixation test

Intervention Type DIAGNOSTIC_TEST

Optical coherence tomography (OCT)

Macular Cube 512x128 or 200x200 scan. OCT will be used to analysis of retinal nerve fiber layer, ganglion cell complex and ganglion-cell/inner plexiform layer

Intervention Type DIAGNOSTIC_TEST

Visual processing speed test

Visual processing speed test will be used for assessing subject visual stimulus search and reach times.

Thirty-two different everyday visual stimuli divided in four complexity groups that were presented along 8 radial visual field positions at three different eccentricities.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Tobii™ Pro Nano hardware package eye-tracking system and Tobii™ Pro Lab - full edition software Macular Integrity Assessment (MAIA™, Centervue, Padova, Italy) Cirrus High definition (HD) - OCT 5000® ,Carl Zeiss Meditec, Dublin,California, USA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Multiple Sclerosis
* Best distant corrected visual acuity equal or greater than 0.7 (decimal scale). Glasses or soft contact lenses users.
* Best close corrected visual acuity equal to or greater than 20/30 (Snellen scale).Glasses or soft contact lenses users.

Exclusion Criteria

* Patients with a history of acute optic neuritis (ON) and/or who experienced an episode of ON \<6 months prior to the study, to avoid potential interference of papilledema with accurate peripapillary RNFL thickness measurements.
* Patients with other retinal and optic nerve diseases, advanced cataracts according to the international Lens Opacities Classification System III (LOCS III) (opacities greater than C2N2)
* Patients with other ophthalmological diseases that could affect central visual acuity
* Subjects with high refractive error (+ - 6 diopters).
* Subjects with other demyelinating disorders (neuromyelitis optica or acute disseminated encephalomyelitis).
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundación Eugenio Rodríguez Pascual

UNKNOWN

Sponsor Role collaborator

Hospital del Rio Hortega

OTHER

Sponsor Role collaborator

Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

IOBA - Universidad de Valladolid

Valladolid, Valladolid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-PI045

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Retinal Biomarkers in Parkinson´s Disease
NCT06929026 ACTIVE_NOT_RECRUITING
Oct-A and Perimetry in Multiple Sclerosis
NCT07175324 NOT_YET_RECRUITING
Functional Assessments in Vision Impairment
NCT06908161 NOT_YET_RECRUITING